Risk factors for progression of brain atrophy in aging
暂无分享,去创建一个
P. Matthews | S. Smith | C. Enzinger | S. Ropele | F. Fazekas | R. Schmidt | H. Schmidt | H. Schmidt | C. Enzinger | R. Schmidt | R. Schmidt | Paul M. Matthews | Stephen M. Smith
[1] S. L. Jeffcoate,et al. Diabetes control and complications: the role of glycated haemoglobin, 25 years on , 2004, Diabetic medicine : a journal of the British Diabetic Association.
[2] Charles DeCarli,et al. Genetic Variation in White Matter Hyperintensity Volume in the Framingham Study , 2004, Stroke.
[3] J. Tuomilehto,et al. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. , 2004, Archives of internal medicine.
[4] I. Deary,et al. What provides cerebral reserve? , 2004, Brain : a journal of neurology.
[5] M Rovaris,et al. Measurement error of two different techniques for brain atrophy assessment in multiple sclerosis , 2004, Neurology.
[6] Carol Brayne,et al. Attrition and bias in the MRC cognitive function and ageing study: an epidemiological investigation , 2004, BMC public health.
[7] H. Kamiya,et al. Insulin, C-peptide, hyperglycemia, and central nervous system complications in diabetes. , 2004, European journal of pharmacology.
[8] P. Matthews,et al. Accelerated evolution of brain atrophy and “black holes” in MS patients with APOE‐ε4 , 2004, Annals of neurology.
[9] Carole Dufouil,et al. Magnetic resonance imaging of the brain in diabetes: the Cardiovascular Determinants of Dementia (CASCADE) Study. , 2004, Diabetes.
[10] Suzanne Craft,et al. For Personal Use. Only Reproduce with Permission the Lancet Publishing Group. Insulin and the Brain Insulin and Neurodegenerative Disease Insulin and Neurodegenerative Disease: Shared and Specific Mechanisms , 2022 .
[11] C. Jack,et al. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD , 2004, Neurology.
[12] J. Gabrieli,et al. Insights into the ageing mind: a view from cognitive neuroscience , 2004, Nature Reviews Neuroscience.
[13] Nick C Fox,et al. Imaging cerebral atrophy: normal ageing to Alzheimer's disease , 2004, The Lancet.
[14] Claude Lenfant,et al. Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[15] M. Nomura,et al. MRI of the brain in diabetes mellitus , 2004, Neuroradiology.
[16] John S. Duncan,et al. A longitudinal study of brain morphometrics using quantitative magnetic resonance imaging and difference image analysis , 2003, NeuroImage.
[17] N. Schuff,et al. Comparison of methods for measuring longitudinal brain change in cognitive impairment and dementia , 2003, Neurobiology of Aging.
[18] Armando Manduca,et al. Methodological considerations for measuring rates of brain atrophy , 2003, Journal of magnetic resonance imaging : JMRI.
[19] Nick C Fox,et al. A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. , 2003, Archives of neurology.
[20] Christian Enzinger,et al. Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study , 2003, The Lancet.
[21] S. Resnick,et al. Longitudinal Magnetic Resonance Imaging Studies of Older Adults: A Shrinking Brain , 2003, The Journal of Neuroscience.
[22] J. Kornhuber,et al. Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals , 2002, Neurology.
[23] Stephen M. Smith,et al. Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.
[24] M. O’Sullivan,et al. Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis , 2002, Neurology.
[25] P. Sachdev,et al. Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals , 2002, Neurology.
[26] G. Biessels,et al. Ageing and diabetes: implications for brain function. , 2002, European journal of pharmacology.
[27] S. Rose,et al. MR image-based measurement of rates of change in volumes of brain structures. Part II: application to a study of Alzheimer's disease and normal aging. , 2002, Magnetic resonance imaging.
[28] D. Siscovick,et al. Alcohol Consumption and Subclinical Findings on Magnetic Resonance Imaging of the Brain in Older Adults: The Cardiovascular Health Study , 2001, Stroke.
[29] Karl J. Friston,et al. A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains , 2001, NeuroImage.
[30] P. Matthews,et al. Normalized Accurate Measurement of Longitudinal Brain Change , 2001, Journal of computer assisted tomography.
[31] S. Resnick,et al. One-year age changes in MRI brain volumes in older adults. , 2000, Cerebral cortex.
[32] O. Sabri,et al. Influence of diabetes mellitus on regional cerebral glucose metabolism and regional cerebral blood flow , 2000, Nuclear medicine communications.
[33] Nick Bryan,et al. Clinical Correlates of Ventricular and Sulcal Size on Cranial Magnetic Resonance Imaging of 3,301 Elderly People , 1999, Neuroepidemiology.
[34] Yasuo Terayama,et al. Risk factors accelerating cerebral degenerative changes, cognitive decline and dementia , 1999, International journal of geriatric psychiatry.
[35] F. Fazekas,et al. MRI white matter hyperintensities , 1999, Neurology.
[36] Nick C Fox,et al. Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer's disease , 1999, The Lancet.
[37] J. Kaye,et al. Brain volume preserved in healthy elderly through the eleventh decade , 1998, Neurology.
[38] S. Woods,et al. Obesity, diabetes and the central nervous system , 1998, Diabetologia.
[39] B L Miller,et al. Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins. , 1998, Stroke.
[40] G. Alexander,et al. Interactive effects of age and hypertension on volumes of brain structures. , 1997, Stroke.
[41] F. Fazekas,et al. Apolipoprotein E polymorphism and silent microangiopathy-related cerebral damage. Results of the Austrian Stroke Prevention Study. , 1997, Stroke.
[42] D. Head,et al. Selective aging of the human cerebral cortex observed in vivo: differential vulnerability of the prefrontal gray matter. , 1997, Cerebral cortex.
[43] D D Blatter,et al. Quantitative volumetric analysis of brain MR: normative database spanning 5 decades of life. , 1995, AJNR. American journal of neuroradiology.
[44] Evidence by magnetic resonance imaging of cerebral alterations of atrophy type in young insulin-dependent diabetic patients , 1994, Journal of endocrinological investigation.
[45] F. Fazekas,et al. Pathologic correlates of incidental MRI white matter signal hyperintensities , 1993, Neurology.
[46] C. Coffey,et al. Quantitative cerebral anatomy of the aging human brain , 1992, Neurology.
[47] A. Alavi,et al. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. , 1987, AJR. American journal of roentgenology.